Skip to content

Evaluation of Efficacy and Safety of Intranasal Dexmedetomidine Premedication for Hypertension Patients

Evaluation of Efficacy and Safety of Intranasal Dexmedetomidine Premedication for Hypertension Patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16008076
Enrollment
Unknown
Registered
2016-03-09
Start date
2016-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension

Interventions

treatment group:intranasal dexmedetomidine 1ug/kg
control group:intranasal 0.9%NS 0.01ml/kg

Sponsors

The First Affiliated Hospital, Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 65 to 75 years old; 2. BMI < 30 kg/m2; 3. ASA II to III level; 4. Grade of Hypertension I to II level.

Exclusion criteria

Exclusion criteria: 1. Refused to participate in the study; 2. Allergic to anaesthetic; 3. Secondary hypertension (such as: pheochromocytoma, renal vascular stenosis, etc.); 4. History of stroke (cerebral infarction, cerebral hemorrhage history); 5. The new diagnosis or untreatment of high blood pressure; 6. Abnormal liver function (Child class B or above); 7. Renal decompensation (SCR > 177 umol/L); 8. Taking clonidine or other alpha 2 agonists; 9. Heart failure, myocardial infarction; 10. Preoperative heart rate is less than 45 BPM, II or III degree atrioventricular block; 11. Asthma patients, patients with sleep apnea syndrome; 12. People with mental illness, patients with long-term use of sedative and analgesic drug.

Design outcomes

Primary

MeasureTime frame
mean arterial pressure;

Secondary

MeasureTime frame
Heart rate;SpO2;OAA/S sedation scale;

Countries

China

Contacts

Public ContactMo Liqiu

The First Affiliated Hospital, Sun Yat-Sen University

mlqiu11220@126.com+86 13924181269

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026